Breaking News: Avalon Acquisition Inc. Stockholders Give Green Light to Exciting Business Merger with The Beneficient Company Group L.P.!

marketinsights04 mins

Avalon Acquisition Inc. Stockholders Approve Proposed Business Combination Transaction with The Beneficient Company Group, L.P. SAN FRANCISCO, June 07, 2023 (GLOBE NEWSWIRE) — Avalon Acquisition Inc. (NASDAQ: AVAC or “Avalon”), a publicly traded special purpose acquisition company, announced that at a stockholder special meeting held on June 6, 2023, Avalon’s stockholders voted to approve its…

Read More

Revolutionizing Psoriasis Treatment: Innovent’s NDA for Picankibart Anti-IL-23p19 Antibody Accepted by NMPA

marketnews04 mins

SAN FRANCISCO and SUZHOU, China , Sept. 26, 2024 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of various diseases, has announced a major milestone. Innovent’s New Drug Application (NDA) for picankibart injection has been accepted by the Center for Drug Evaluation…

Read More

Quadro Acquisition: One Corp to Merge with Group of Greg Lindberg’s Companies, Estimated Pro Forma Enterprise Value of $3 Billion

SpotlightSource03 mins

LOS ANGELES, Calif., Jan. 17, 2024 (SEND2PRESS NEWSWIRE) — Quadro Acquisition One Corp., a NASDAQ-listed Special Purpose Acquisition Company (“Quadro SPAC”) has agreed to acquire a group of seven companies in the sports collectibles, software, cloud-based IT and healthcare services segments with an estimated pro-forma enterprise value of $3 billion (referred to as the “Global…

Read More

Breaking News: US Federal Reserve Slashes Interest Rates by 50 Basis Points in Response to COVID Pandemic

marketnews05 mins

The US Federal Reserve Cuts Key Interest Rate Introduction The US Federal Reserve announced on Wednesday that it would be cutting its key lending rate by half a percentage-point. This is the first rate reduction since the beginning of the Covid-19 pandemic and comes just weeks before the November presidential election. The move is aimed…

Read More

“Rosen National Trial Lawyers Urges Investors of Cardlytics Inc. to Take Action”

marketinsights03 mins

Investor Alert: Rosen Law Firm Investigates Potential Securities Claims Against Cardlytics, Inc. What’s Going On? The Rosen Law Firm, a renowned global investor rights law firm, recently announced an investigation into potential securities claims involving Cardlytics, Inc. (NASDAQ: CDLX). The allegations suggest that Cardlytics may have disseminated materially misleading business information to the investing public,…

Read More